Follow
Iain Macpherson
Iain Macpherson
School of Cancer Sciences, University of Glasgow
Verified email at glasgow.ac.uk
Title
Cited by
Cited by
Year
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
U Banerji, CML van Herpen, C Saura, F Thistlethwaite, S Lord, V Moreno, ...
The Lancet Oncology 20 (8), 1124-1135, 2019
4032019
Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression
MA Dozynkiewicz, NB Jamieson, I MacPherson, J Grindlay, ...
Developmental cell 22 (1), 131-145, 2012
3562012
Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry
VG Brunton, IRJ MacPherson, MC Frame
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1692 (2-3), 121-144, 2004
2292004
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
NC Turner, B Kingston, LS Kilburn, S Kernaghan, AM Wardley, ...
The Lancet Oncology 21 (10), 1296-1308, 2020
2242020
Comparing breast cancer multiparameter tests in the OPTIMA prelim trial: no test is more equal than the others
JMS Bartlett, J Bayani, A Marshall, JA Dunn, A Campbell, C Cunningham, ...
JNCI: Journal of the National Cancer Institute 108 (9), djw050, 2016
2132016
N-WASP coordinates the delivery and F-actin–mediated capture of MT1-MMP at invasive pseudopods
X Yu, T Zech, L McDonald, EG Gonzalez, A Li, I Macpherson, JP Schwarz, ...
Journal of cell biology 199 (3), 527-544, 2012
1892012
Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors
GD Demetri, P Lo Russo, IRJ MacPherson, D Wang, JA Morgan, ...
Clinical Cancer Research 15 (19), 6232-6240, 2009
1702009
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib
A Serrels, IRJ Macpherson, TRJ Evans, FY Lee, EA Clark, OJ Sansom, ...
Molecular cancer therapeutics 5 (12), 3014-3022, 2006
1412006
Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice
H Cain, IR Macpherson, M Beresford, SE Pinder, J Pong, JM Dixon
Clinical oncology 29 (10), 642-652, 2017
1252017
CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer
IR Macpherson, E Rainero, LE Mitchell, PVE van den Berghe, C Speirs, ...
Journal of cell science 127 (18), 3893-3901, 2014
1062014
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels
D Novo, N Heath, L Mitchell, G Caligiuri, A MacFarlane, D Reijmer, ...
Nature Communications 9 (1), 5069, 2018
1052018
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
JR Hernandez-Fernaud, E Ruengeler, A Casazza, LJ Neilson, E Pulleine, ...
Nature communications 8 (1), 14206, 2017
1002017
Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells
E Dornier, N Rabas, L Mitchell, D Novo, S Dhayade, S Marco, G Mackay, ...
Nature communications 8 (1), 2255, 2017
802017
p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism
IR Macpherson, S Hooper, A Serrels, L McGarry, BW Ozanne, ...
Oncogene 26 (36), 5214-5228, 2007
772007
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
L Rooshenas, LJ Scott, JM Blazeby, CA Rogers, KM Tilling, S Husbands, ...
Journal of clinical epidemiology 106, 108-120, 2019
742019
A phase I expansion cohorts study of SYD985 in heavily pretreated patients with HER2-positive or HER2-low metastatic breast cancer.
C Saura, F Thistlethwaite, U Banerji, S Lord, V Moreno, I MacPherson, ...
Journal of Clinical Oncology 36 (15_suppl), 1014-1014, 2018
702018
Genomic profile of advanced breast cancer in circulating tumour DNA
B Kingston, RJ Cutts, H Bye, M Beaney, G Walsh-Crestani, S Hrebien, ...
Nature communications 12 (1), 2423, 2021
642021
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial
G Argilés, MP Saunders, F Rivera, A Sobrero, CG Ponce, S Cascinu, ...
European journal of cancer 51 (8), 942-949, 2015
622015
The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: a qualitative systematic review and thematic synthesis
N Peddie, S Agnew, M Crawford, D Dixon, I MacPherson, L Fleming
The Breast 58, 147-159, 2021
572021
PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness
N Rabas, S Palmer, L Mitchell, S Ismail, A Gohlke, JS Riley, SWG Tait, ...
Journal of Cell Biology 220 (12), e202006049, 2021
552021
The system can't perform the operation now. Try again later.
Articles 1–20